Physician profile
Scott Zeitlin
NPI 1033155239
$4,734.75
in general payments reported to CMS, 2019-2025
35 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $1,730 · 2021: $249 · 2022: $475 · 2023: $1,381 · 2024: $278 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,151 · Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,150.56 |
| Food and Beverage | $727.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,774.77 | 2020-2023 | Ams Ambicor |
| Teleflex LLC | $283.58 | 2022 | |
| Astellas Pharma US INC | $198.39 | 2019-2025 | Xtandi, Myrbetriq |
| Shire North American Group INC | $109.34 | 2019 | |
| Blue Earth Diagnostics | $97.03 | 2021-2024 | |
| Baxter Healthcare | $95.49 | 2023-2024 | Floseal, Tisseel |
| Abbvie INC. | $91.24 | 2021-2024 | Botox |
| Tolmar Pharmaceuticals, INC. | $85.74 | 2019-2022 | |
| Coloplast Corp | $84.04 | 2020-2022 | |
| Janssen Biotech, INC. | $70.69 | 2023-2025 | Erleada |
| Abbott Laboratories | $65.52 | 2019-2020 | |
| Antares Pharma, INC. | $63.61 | 2019-2023 | Tlando, Xyosted |
| Procept Biorobotics Corporation | $61.00 | 2025 | |
| Valeritas, INC. | $59.02 | 2019 | |
| Urogen Pharma, INC. | $50.98 | 2022-2023 | Jelmyto |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $49.91 | 2024-2025 | Prolaris |
| Novo Nordisk INC | $48.30 | 2019 | |
| Endo Pharmaceuticals INC. | $46.76 | 2019-2021 | |
| Lilly USA, LLC | $41.98 | 2020 | |
| Acerus Pharmaceuticals Corporation | $32.12 | 2021 | |
| Dendreon Pharmaceuticals LLC | $30.46 | 2021 | |
| Telix Pharmaceuticals | $29.02 | 2025 | Illuccix |
| Becton, Dickinson and Company | $26.85 | 2024 | Bard Urinary Drainage Bag |
| Amgen INC. | $25.28 | 2019 | |
| Verity Pharmaceuticals INC. | $24.35 | 2022 | |
| Convatec INC. | $24.18 | 2025 | |
| Progenics Pharmaceuticals, INC. | $22.53 | 2024 | |
| Travere Therapeutics, INC. | $21.49 | 2021 | |
| Medline Industries LP | $20.00 | 2025 | |
| Senseonics, Incorporated | $20.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.31 | 2024 | |
| Smith+Nephew, INC. | $18.66 | 2021 | |
| Metuchen Pharmaceuticals | $16.83 | 2019 | |
| Accord Healthcare, INC. | $14.21 | 2023 | |
| Zyla Life Sciences, INC. | $12.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Zeitlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.